Prot# DR-DSG-301: A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021

Project: Research project

Project Details

StatusFinished
Effective start/end date10/26/064/3/08

Funding

  • Duramed Pharmaceuticals, Inc. (DR-DSG-301)